"/> Novus Biologicals™ Peptide bloquant d’anticorps Si… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Siglec-11

Réf. : BL-RE-105018Réf. fabricant : 18227745 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
114132
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77025. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the carboxy terminus of human Siglec11.

Points forts

Source

Synthetic

(Accession #: NP_443116) The Siglec-11 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-105018
Réf. fabricant18227745
Gene ID (Entrez)114132
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77025. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènesialic acid binding Ig-like lectin 11, sialic acid-binding Ig-like lectin 11, Sialic acid-binding lectin 11, siglec-11
Symbole de gène(s)SIGLEC11
Type de produitSiglec-11
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the carboxy terminus of human Siglec11
Une question, une configuration particulière ?
Contactez-nous pour un devis.